 diabet intervent studi multi-intervent trial niddm object random multi-intervent trial efficaci intensifi health educ ihe metabol control level coronari risk factor incid ischem heart diseas ihd research design and method intervent group benefit clofibr acid double-blind studi thirty-nin middle-ag patient non-insulin-depend diabet niddm studi diet screen phase convent dietari treatment follow-up control group differ diabet outpati clinic standard surveil intervent group ihe dietari advic antialcohol educ way physic activ result randomli ihe patient clofibr acid/day other placebo ihe improv glucos control blood glucos level yr control mM ihe group mM ihe clofibr acid group mM glycem control antidiabet drug yr antidiabet drug control ihe group ihe clofibr acid group cutoff limit drug applic postprandi blood glucos equal mM ratio fatti acid physic activ score blood pressur tobacco alcohol consumpt ihe ihe effect calori percentag fat diet bodi weight import find signific increas blood cholesterol group mM clofibr increas triglycerid level mM incid rate myocardi infarct control subject ihe group ihe clofibr acid group correspond rate ihd incid men myocardi infarct wherea women ecg criteria ihd case death cardiovascular diseas cirrhosi neoplasia predomin caus death rate control subject ihe group patient ihe clofibr acid conclus ihe substanti benefit control glycemia need antidiabet drug cluster risk factor effect control blood lipid major reason failur ihe effect lower blood pressur clofibr acid cardiovascular complic clofibr acid effect triglycerid